Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
Actual shortage: | 249 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2020-02-21 | 2020-05-01 | 106931 |
TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2021-06-17 | 2021-07-09 | 141107 |
TEVA-CARVEDILOL | 3.125MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174598 |
ACT BORTEZOMIB | 3.5MG | POWDER FOR SOLUTION | Resolved | 2020-01-30 | 2020-05-29 | 104930 |
ACT BORTEZOMIB | 3.5MG | POWDER FOR SOLUTION | Resolved | 2020-09-25 | 2020-10-22 | 125031 |
TEVA-AMPHETAMINE XR | 3.75MG 3.75MG 3.75MG 3.75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-06 | 2019-01-31 | 60068 |
TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Actual shortage | 2024-04-11 | 2024-04-11 | 224895 |
TEVA-LENOLTEC NO. 2 | 300MG 15MG 15MG | TABLET | Resolved | 2017-03-17 | 2017-09-05 | 3118 |
TEVA-LENOLTEC NO. 2 | 300MG 15MG 15MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118951 |
TEVA-LENOLTEC NO. 1 | 300MG 15MG 8MG | TABLET | Resolved | 2020-05-14 | 2020-07-23 | 115199 |
TEVA-LENOLTEC NO. 1 | 300MG 15MG 8MG | TABLET | Resolved | 2021-01-22 | 2021-02-25 | 132254 |
TEVA-LENOLTEC NO. 1 | 300MG 15MG 8MG | TABLET | Resolved | 2021-03-04 | 2021-04-01 | 135111 |
TEVA-LENOLTEC NO. 1 | 300MG 15MG 8MG | TABLET | Resolved | 2021-03-11 | 2021-03-25 | 135549 |
TEVA-LENOLTEC NO. 1 | 300MG 15MG 8MG | TABLET | Resolved | 2021-04-08 | 2021-05-27 | 137206 |
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2022-06-03 | 2023-02-11 | 161940 |
TEVA-EMTRICITABINE/TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2022-04-21 | 2023-06-21 | 159201 |
TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Resolved | 2021-06-10 | 2021-09-10 | 140681 |
TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Resolved | 2023-11-03 | 2024-03-07 | 209122 |
TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Actual shortage | 2024-04-11 | 2024-04-18 | 224898 |
TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2017-03-15 | 2017-12-15 | 2986 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |